BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36054864)

  • 1. [Guillain-Barré syndrome and other autoimmune neurophaties: current therapy].
    Expósito J; Carrera L; Natera D; Nolasco G; Nascimiento A; Ortez C
    Medicina (B Aires); 2022 Aug; 82 Suppl 3():82-88. PubMed ID: 36054864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
    Alanazy MH; Bakry SS; Alqahtani A; AlAkeel NS; Alazwary N; Osman AM; Mustafa RA; Al-Harbi TM; Abdulmana SO; Amper AC; Aldughaythir Y; Ali AS; Makkawi S; Maglan A; Alamoudi L; Alsulaiman F; Alabdali M; AlShareef AA; Abuzinadah AR; Bamaga AK
    BMC Neurol; 2021 Jul; 21(1):275. PubMed ID: 34253174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To be, or not to be… Guillain-Barré Syndrome.
    Florian IA; Lupan I; Sur L; Samasca G; Timiș TL
    Autoimmun Rev; 2021 Dec; 20(12):102983. PubMed ID: 34718164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral Facial Palsy and Hyperreflexia as the Main Clinical Presentation in Guillain-Barré Syndrome.
    Albuainain G
    Am J Case Rep; 2021 Oct; 22():e932757. PubMed ID: 34597290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with Guillain-Barré syndrome in a neurological Intensive Care Unit.
    González P; García X; Guerra A; Arango JC; Delgado H; Uribe CS; Sará J; López de Mesa JC; Hernández O
    Neurologia; 2016; 31(6):389-94. PubMed ID: 25542501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guillain-Barre syndrome and its frontiers].
    Azulay JP; Verschueren A; Attarian S; Pouget J
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S21-6. PubMed ID: 12690657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare mimic of acute stroke: rapidly progressing Miller-Fisher Syndrome to acute motor and sensory axonal neuropathy variant of Guillain-Barre Syndrome.
    de Castillo LLC; Diestro JDB; Ignacio KHD; Pasco PMD
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome.
    Arcila-Londono X; Lewis RA
    Semin Neurol; 2012 Jul; 32(3):179-86. PubMed ID: 23117942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
    van Doorn PA
    Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
    Puma A; Benoit J; Sacconi S; Uncini A
    BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [History of Guillain-Barré Syndrome].
    Kusunoki S
    Brain Nerve; 2015 Nov; 67(11):1295-303. PubMed ID: 26560944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
    Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
    Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Guillain-Barré syndrome.
    Estridge R; Iskander M
    JAAPA; 2015 Jul; 28(7):19-22. PubMed ID: 26075345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes.
    Tatsumoto M; Misawa S; Kokubun N; Sekiguchi Y; Hirata K; Kuwabara S; Yuki N
    Muscle Nerve; 2015 Jun; 51(6):811-4. PubMed ID: 25287079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guillain-Barré syndrome in childhood].
    Kollár K; Liptai Z; Rosdy B; Móser J
    Ideggyogy Sz; 2009 Nov; 62(11-12):399-404. PubMed ID: 20025130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome and variants.
    Dimachkie MM; Barohn RJ
    Neurol Clin; 2013 May; 31(2):491-510. PubMed ID: 23642721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
    Kalita J; Kumar M; Misra UK
    Pediatr Crit Care Med; 2019 Jul; 20(7):652-659. PubMed ID: 30985608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.